Moorestown, New Jersey, United States
BiotecDATA™
welcome to BiotecDATA™
BiotecDATA™ is where we make cents and sense out of the data
The top selling prescription drugs by revenue
Three Malls in Three States: A Weekend Shopping Trip Under Coronavirus
Americans in Ohio, Texas and Georgia are eager to get out of their homes; a patchwork of mask rules and nervous retail workers
By Sarah Nassauer in Toledo, Ohio; Cameron McWhirter in Atlanta
and Elizabeth Findell in Houston
May 18, 2020 5:30 am ET
Small-Business Loan Deadline Poses Test for Mnuchin
Small-Business Loan Deadline Poses Test for Mnuchin
The Treasury Secretary has given big companies until May 14 to return their Paycheck Protection Program loans or face criminal liability. Many borrowers are rebuffing those demands.
Coronavirus Live Updates: Full Economic Recovery May Await Vaccine, Fed Chairman Says
Seeking to encourage testing, Gov. Andrew M. Cuomo of New York has a nasal swab on live television.
President Trump, calling in to a charity golf exhibition, says he misses sports and wants “big, big stadiums loaded with people.”
https://www.nytimes.com/2020/05/17/us/coronavirus-cases-deaths.html
iShares Nasdaq Biotechnology ETF
iShares Nasdaq Biotechnology ETF
https://www.blackrock.com/us/individual/products/239699/
INVESTMENT OBJECTIVE
The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
as of Aug 26, 2020 % of Market Value
Biotechnology 78.60
Life Sciences Tools & Services 9.84
Pharmaceuticals 9.11
Health Care Equipment 1.06
Health Care Services 0.98
Cash and/or Derivatives 0.14
Health Care Supplies 0.11
Health Care Distributors 0.09
Specialty Chemicals 0.07
https://seekingalpha.com/symbol/IBB
iShares U.S. Pharmaceuticals ETF
https://www.blackrock.com/us/individual/products/239519/
INVESTMENT OBJECTIVE
The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
as of Aug 26, 2020 % of Market Value
Pharmaceuticals 96.44
Biotechnology 3.24
Cash and/or Derivatives 0.32
https://seekingalpha.com/symbol/IHE
Economics
Jefferson County Bankruptcy Foreshadows Fate of Cities in Crisis
By Martin Z BraunMay 13, 2020, 9:06 AM EDT
- After revenue loss, Alabama county cut back then went bankrupt
- States, cities facing big budget gaps as jobs, taxes disappear
API Sourcing: The Supply Side for US-Marketed Drugs
By Patricia Van Arnum - DCAT Editorial Director
November 20, 2019
Brian Chappatta
SPDR Select Sector Fund - Health Care (XLV)
SPDR Select Sector Fund - Health Care (XLV)
HOLDINGS AND WEIGHTINGS as of as of 7:00 AM ET 01/22/2021 . Holdings and weightings are subject to change.
https://www.sectorspdr.com/sectorspdr/sector/xlv/portfolio
JNJ JOHNSON + JOHNSON COMMON STOCK USD1.0 9.60%
UNH UNITEDHEALTH GROUP INC COMMON STOCK USD.01 7.59%
PFE PFIZER INC COMMON STOCK USD.05 4.57%
MRK MERCK + CO. INC. COMMON STOCK USD.5 4.63%
ABT ABBOTT LABORATORIES COMMON STOCK 4.51%
ABBV ABBVIE INC COMMON STOCK USD.01 4.43%
TMO THERMO FISHER SCIENTIFIC INC COMMON STOCK 4.58%
LLY ELI LILLY + CO COMMON STOCK 3.62%
MDT MEDTRONIC PLC COMMON STOCK USD.1 3.58%
DHR DANAHER CORP COMMON STOCK USD.01 3.32%
AMGN AMGEN INC COMMON STOCK USD.0001 3.31%
BMY BRISTOL MYERS SQUIBB CO COMMON STOCK USD .1 3.27%
GILD GILEAD SCIENCES INC COMMON STOCK USD.001 1.89%
https://www.sectorspdr.com/sectorspdr/sector/xlv/performance
HEALTH CARE as of 3:43 PM ET 09/10/2020 XLV
Estimate Weight of XLV Components in the S&P 500 as of 09/09/2020
https://www.nasdaq.com/market-activity/funds-and-etfs/xlv/dividend-history
Barron's
Want to Use ETFs to Play Biotech? Choose Wisely.
By Evie Liu Jan. 14, 2021 12:27 pm ET
RELATED MARKET DATA
Biotech ETFs: More diversified funds reduce risk – Barron’s
Jan. 16, 2021 8:14 PM ET ARK Genomic Revolution Multi-Sector ETF (ARKG)
By: Dulan Lokuwithana, SA News Editor 19 Comments
- Given the difficulty in stock picking in the biotech space, the investors are better off with more diversified ETFs focused on the industry, according to an article in the latest issue of Barron’s.
https://seekingalpha.com/news/3652041-biotech-etfs-diversified-funds-reduce-risk-barron-s
UK restricts parallel export of nearly 200 drugs
Covid-19: UK restricts parallel export of nearly 200 drugs, threatening its biopharma industry
13 MAY 2020
WDNA WisdomTree BioRevolution Fund
WDNA
WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index. Learn more about the Index that WDNA is designed to track.
https://www.wisdomtree.com/etfs/megatrends/wdna
Holdings
As of 01/28/2022 Weight of Top 10 Within Portfolio
Name Weight (%)
Astrazeneca Plc-Spons ADR 2.38%
Pfizer Inc 2.09%
Eli Lilly & Co 1.98%
PerkinElmer Inc 1.97%
Thermo Fisher Scientific Inc1.82%
GlaxoSmithKline PLC 1.76%
Vertex Pharmaceuticals Inc1.70%
Zoetis Inc 1.68%
Danaher Corp 1.68%
Gilead Sciences Inc 1.68%
Remaining Portfolio 81.26%
Fidelity® Select Pharmaceuticals Portfolio
Fidelity® Select Pharmaceuticals Portfolio
https://fundresearch.fidelity.com/mutual-funds/composition/316390442
Fidelity Select Pharmaceuticals (FPHAX)
https://www.nasdaq.com/market-activity/funds-and-etfs/fphax
Fidelity® Select Biotechnology Portfolio
https://fundresearch.fidelity.com/mutual-funds/composition/316390772
Fidelity Select Biotechnology Pt (FBIOX)
https://www.nasdaq.com/market-activity/funds-and-etfs/fbiox
Fidelity® Select Health Care Portfolio
https://fundresearch.fidelity.com/mutual-funds/composition/316390301
Fidelity Select Health Care (FSPHX)
https://www.nasdaq.com/market-activity/funds-and-etfs/fsphx
38th Annual J.P. Morgan Healthcare Conference Slideshows
ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals (ACAD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 15, 2020 6:06 PM ET|3 comments | About: ACADIA Pharmaceuticals Inc. (ACAD) )
Amgen Inc. (AMGN)
ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (ACAD)
Amgen (AMGN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 15, 2020 6:13 PM ET | About: Amgen Inc. (AMGN)
EXACT Sciences Corporation (EXAS)
ACADIA Pharmaceuticals Inc. (ACAD)
EXACT Sciences Corporation (EXAS)
Exact Sciences (EXAS) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 16, 2020 1:51 PM ET | About: Exact Sciences Corporation (EXAS)
Moderna, Inc. (MRNA)
Alexion Pharmaceuticals, Inc. (ALXN)
EXACT Sciences Corporation (EXAS)
Moderna (MRNA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 15, 2020 3:27 PM ET|3 comments | About: Moderna, Inc. (MRNA)
Alexion Pharmaceuticals, Inc. (ALXN)
Alexion Pharmaceuticals, Inc. (ALXN)
Alexion Pharmaceuticals, Inc. (ALXN)
Alexion Pharmaceuticals (ALXN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 15, 2020 3:27 PM ET | About: Alexion Pharmaceuticals, Inc. (ALXN)
Insulet Corporation (PODD)
Alexion Pharmaceuticals, Inc. (ALXN)
Alexion Pharmaceuticals, Inc. (ALXN)
Insulet Corporation (PODD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 15, 2020 1:45 PM ET | About: Insulet Corporation (PODD)
38th Annual J.P. Morgan Healthcare Conference Slideshows
Amarin Corporation plc (AMRN)
BriaCell Therapeutics Corp. (BCTXF)
BriaCell Therapeutics Corp. (BCTXF)
Amarin (AMRN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 17, 2020 9:31 AM ET | About: Amarin Corporation plc (AMRN)
BriaCell Therapeutics Corp. (BCTXF)
BriaCell Therapeutics Corp. (BCTXF)
BriaCell Therapeutics Corp. (BCTXF)
BriaCell Therapeutics (BCTXF) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 16, 2020 3:11 PM ET | About: BriaCell Therapeutics Corp. (BCTXF)
Editas Medicine, Inc. (EDIT)
BriaCell Therapeutics Corp. (BCTXF)
Stemline Therapeutics, Inc. (STML)
Editas Medicine (EDIT) Investor Presentation - Slideshow
Jan. 16, 2020 2:00 PM ET | About: Editas Medicine, Inc. (EDIT)
Stemline Therapeutics, Inc. (STML)
Stemline Therapeutics, Inc. (STML)
Stemline Therapeutics, Inc. (STML)
Stemline Therapeutics (STML) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 16, 2020 1:59 PM ET | About: Stemline Therapeutics, Inc. (STML)
BeiGene, Ltd. (BGNE)
Stemline Therapeutics, Inc. (STML)
Agilent Technologies, Inc. (A)
Beigene (BGNE) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 16, 2020 1:53 PM ET | About: BeiGene, Ltd. (BGNE)
Agilent Technologies, Inc. (A)
Stemline Therapeutics, Inc. (STML)
Agilent Technologies, Inc. (A)
Agilent Technologies (A) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 15, 2020 6:10 PM ET | About: Agilent Technologies, Inc. (A)
37th Annual J.P. Morgan Healthcare Conference Slideshows
CVS Health Corporation (CVS)
Karuna Therapeutics, Inc. (KRTX)
CVS Health Corporation (CVS)
CVS Health Corporation (CVS) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 15, 2020 12:57 PM ET|7 comments | About: CVS Health Corporation (CVS)
ImmunoGen, Inc. (IMGN)
Karuna Therapeutics, Inc. (KRTX)
CVS Health Corporation (CVS)
ImmunoGen (IMGN) Investor Presentation - Slideshow
Jan. 16, 2020 1:30 PM ET | About: ImmunoGen, Inc. (IMGN)
Karuna Therapeutics, Inc. (KRTX)
Karuna Therapeutics, Inc. (KRTX)
Karuna Therapeutics, Inc. (KRTX)
Karuna Therapeutics (KRTX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 17, 2020 11:16 AM ET | About: Karuna Therapeutics, Inc. (KRTX)
ABIOMED, Inc. (ABMD)
Boston Scientific Corporation (BSX)
Karuna Therapeutics, Inc. (KRTX)
Abiomed (ABMD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 17, 2020 11:07 AM ET | About: Abiomed, Inc. (ABMD)
Boston Scientific Corporation (BSX)
Boston Scientific Corporation (BSX)
Boston Scientific Corporation (BSX)
Boston Scientific (BSX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 15, 2020 6:05 PM ET | About: Boston Scientific Corporation (BSX)
Becton, Dickinson and Company (BDX)
Boston Scientific Corporation (BSX)
Boston Scientific Corporation (BSX)
Becton Dickinson (BDX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
Jan. 15, 2020 6:09 PM ET | About: Becton, Dickinson and Company (BDX)
Mapped: The World’s Top 10 Cities in 2035
Published 2 days ago on October 18, 2019By Iman Ghosh
Mapped: Where Will The Top 10 Cities Be in 2035?
Top 10 Cities by Projected GDP
Top 10 Cities by Future Population
Mapped: The World’s Top 10 Cities in 2035Published 2 days ago on October 18, 2019By Iman Ghosh
Mapped: The World’s Top 10 Cities in 2035
Published 2 days ago on October 18, 2019
By
https://www.visualcapitalist.com/top-10-cities/
Weighing The Week Ahead: Earnings Season Opportunities
Oct. 20, 2019 6:55 AM ET|28 comments | Includes: BAPR, BAUG, BIBL, BJUL, BJUN, BOCT, CHGX, CRF, DDM, DIA, DMRL, DOG, DUSA, DXD, EDOW, EEH, EPS, EQL, EQWL, ESGL, FEX, FWDD, GSEW, HUSV, IVV, IWL, IWM, JHML, JKD, OMFS, OTPIX, PAPR, PAUG, PJAN, PJUN, PMOM, PPLC, PSQ, QID, QLD, QQEW, QQQ, QQQE, QQXT, RSP, RVRS, RWL, RWM, RWSL, RYARX, RYRSX, SCAP, SCHX, SDOW, SDS, SFLA, SFY, SH, SMLL, SPDN, SPLX, SPSM, SPUU, SPXE, SPXL, SPXN, SPXS, SPXT, SPXU, SPXV, SPY, SQQQ, SRTY, SSO, SSPY, SYE, TNA, TQQQ, TRND, TWM, TZA, UAUG, UDOW, UDPIX, UJAN, UOCT, UPRO, URTY, USA, USMC, UWM, VFINX, VOO, VTWO, VV, ZF
Jeff MillerValue, Growth
https://seekingalpha.com/article/4297479-weighing-week-ahead-earnings-season-opportunities
2019 Q3 - Results
Intercept Pharmaceuticals, Inc. (ICPT)
Intercept Pharmaceuticals, Inc. (ICPT)
Intercept Pharmaceuticals, Inc. (ICPT)
Intercept Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation
Nov. 5, 2019 11:26 AM ET | About: Intercept Pharmaceuticals, Inc. (ICPT)
Neurocrine Biosciences, Inc. (NBIX)
Intercept Pharmaceuticals, Inc. (ICPT)
Intercept Pharmaceuticals, Inc. (ICPT)
Neurocrine Biosciences, Inc. 2019 Q3 - Results - Earnings Call Presentation
Nov. 5, 2019 7:48 AM ET | About: Neurocrine Biosciences, Inc. (NBIX)
: Amarin Corporation plc (AMRN)
Intercept Pharmaceuticals, Inc. (ICPT)
Becton, Dickinson and Company (BDX)
Amarin Corporation plc 2019 Q3 - Results - Earnings Call Presentation
Nov. 5, 2019 3:32 PM ET | About: Amarin Corporation plc (AMRN)
Becton, Dickinson and Company (BDX)
Becton, Dickinson and Company (BDX)
Becton, Dickinson and Company (BDX)
Becton, Dickinson and Company 2019 Q4 - Results - Earnings Call Presentation
Nov. 5, 2019 3:32 PM ET|1 comment | About: Becton, Dickinson and Company (BDX)
QIAGEN N.V. (QGEN)
Becton, Dickinson and Company (BDX)
IN.PACT™ Admiral™ DCB
QIAGEN N.V. 2019 Q3 - Results - Earnings Call Presentation
Nov. 5, 2019 2:28 PM ET | About: QIAGEN N.V. (QGEN)
IN.PACT™ Admiral™ DCB
Becton, Dickinson and Company (BDX)
IN.PACT™ Admiral™ DCB
Four-Year Data from the IN.PACT Global Study Highlight Durable Performance and Safety of IN.PACT™ Admiral™ DCB
Tue November 5, 2019 1:15 PM|GlobeNewswire|About: MDT
Longest-Term Data from a Real-World PAD Patient Population Presented at VIVA
DUBLIN and LAS VEGAS, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (MDT)
2019 Q3 - Results
Celgene Corporation (CELG)
Celgene Corporation (CELG)
Celgene Corporation (CELG)
Celgene Corporation 2019 Q3 - Results - Earnings Call Presentation
Nov. 1, 2019 11:58 AM ET|5 comments | About: Celgene Corporation (CELG)
Exelixis, Inc. (EXEL)
Celgene Corporation (CELG)
Celgene Corporation (CELG)
Exelixis, Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 31, 2019 3:51 PM ET|1 comment | About: Exelixis, Inc. (EXEL)
Sanofi (SNY)
Celgene Corporation (CELG)
bluebird bio, Inc. (BLUE)
bluebird bio, Inc. (BLUE)
Vertex Pharmaceuticals Incorporated (VRTX)
bluebird bio, Inc. (BLUE)
bluebird bio (BLUE) Investor Presentation - Slideshow
Nov. 2, 2019 2:03 PM ET|1 comment | About: bluebird bio, Inc. (BLUE)
GlaxoSmithKline plc (GSK)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX)
GlaxoSmithKline plc 2019 Q3 - Results - Earnings Call Presentation
Oct. 30, 2019 10:13 AM ET | About: GlaxoSmithKline plc (GSK)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated 2019 Q3 - Results - Earnings Call Presentation
Nov. 3, 2019 10:53 PM ET | About: Vertex Pharmaceuticals Incorporated (VRTX)
2019 Q3 - Results
Merck & Co., Inc. (MRK)
Incyte Corporation (INCY)
Merck & Co., Inc. (MRK)
Merck & Co., Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 29, 2019 8:34 AM ET | About: Merck & Co., Inc. (MRK)
Pfizer Inc. (PFE)
Incyte Corporation (INCY)
Merck & Co., Inc. (MRK)
Pfizer Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 29, 2019 7:26 AM ET | About: Pfizer Inc. (PFE)
Incyte Corporation (INCY)
Incyte Corporation (INCY)
Incyte Corporation (INCY)
Incyte Corporation 2019 Q3 - Results - Earnings Call Presentation
Oct. 29, 2019 9:32 AM ET | About: Incyte Corporation (INCY)
Amgen Inc. (AMGN)
Seattle Genetics, Inc. (SGEN)
Incyte Corporation (INCY)
Amgen Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 29, 2019 4:59 PM ET | About: Amgen Inc. (AMGN)
NovoCure Limited (NVCR)
Seattle Genetics, Inc. (SGEN)
Seattle Genetics, Inc. (SGEN)
.
NovoCure Limited 2019 Q3 - Results - Earnings Call Presentation
Oct. 31, 2019 12:28 PM ET | About: NovoCure Limited (NVCR)
Seattle Genetics, Inc. (SGEN)
Seattle Genetics, Inc. (SGEN)
Seattle Genetics, Inc. (SGEN)
Seattle Genetics, Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 29, 2019 8:04 PM ET | About: Seattle Genetics, Inc. (SGEN)
2019 Q3 - Results
Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 23, 2019 9:57 AM ET | About: Thermo Fisher Scientific Inc. (TMO)
Novartis AG (NVS)
Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific Inc. (TMO)
Novartis AG 2019 Q3 - Results - Earnings Call Presentation
Oct. 22, 2019 6:53 AM ET | About: Novartis AG (NVS)
Amarin Corporation plc (AMRN)
Thermo Fisher Scientific Inc. (TMO)
Amarin Corporation plc (AMRN)
Amarin Corporation (AMRN) Investor Presentation - Slideshow
Oct. 3, 2019 10:59 AM ET|11 comments | About: Amarin Corporation plc (AMRN)
AstraZeneca PLC (AZN)
Gilead Sciences, Inc. (GILD)
Amarin Corporation plc (AMRN)
AstraZeneca PLC 2019 Q3 - Results - Earnings Call Presentation
Oct. 24, 2019 10:19 AM ET | About: AstraZeneca PLC (AZN)
Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 24, 2019 4:31 PM ET|1 comment | About: Gilead Sciences, Inc. (GILD)
Illumina, Inc. (ILMN)
Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (GILD)
Illumina, Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 24, 2019 6:25 PM ET|2 comments | About: Illumina, Inc. (ILMN)
2019 Q3 - Results
Boston Scientific Corporation (BSX)
About: Alexion Pharmaceuticals, Inc. (ALXN)
Boston Scientific Corporation (BSX)
Boston Scientific Corporation 2019 Q3 - Results - Earnings Call Presentation
Oct. 23, 2019 8:21 AM ET | About: Boston Scientific Corporation (BSX)
Alkermes plc (ALKS)
About: Alexion Pharmaceuticals, Inc. (ALXN)
Boston Scientific Corporation (BSX)
Alkermes plc 2019 Q3 - Results - Earnings Call Presentation
Oct. 23, 2019 7:57 AM ET | About: Alkermes plc (ALKS)
About: Alexion Pharmaceuticals, Inc. (ALXN)
About: Alexion Pharmaceuticals, Inc. (ALXN)
About: Alexion Pharmaceuticals, Inc. (ALXN)
Alexion Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 23, 2019 9:59 AM ET | About: Alexion Pharmaceuticals, Inc. (ALXN)
Veracyte, Inc. (VCYT)
Eli Lilly and Company (LLY)
About: Alexion Pharmaceuticals, Inc. (ALXN)
Veracyte, Inc. 2019 Q3 - Results - Earnings Call Presentation
Oct. 23, 2019 12:37 AM ET | About: Veracyte, Inc. (VCYT)
Eli Lilly and Company (LLY)
Eli Lilly and Company (LLY)
Eli Lilly and Company (LLY)
Eli Lilly and Company 2019 Q4 - Results - Earnings Call Presentation
Jan. 30, 2020 10:25 AM ET | About: Eli Lilly and Company (LLY)
Biogen Inc. (BIIB)
Eli Lilly and Company (LLY)
Eli Lilly and Company (LLY)
Biogen Inc. 2019 Q4 - Results - Earnings Call Presentation
Jan. 30, 2020 7:56 AM ET|1 comment | About: Biogen Inc. (BIIB)
BAC Global HealthCare Conference & ESMO Congress 2019
Incyte Corporation (INCY)
Incyte Corporation (INCY)
Incyte Corporation (INCY)
Incyte Corporation (INCY) Presents At Bank of America Merrill Lynch Global Healthcare Conference - Slideshow
Sep. 19, 2019 10:11 AM ET | About: Incyte Corporation (INCY)
About: Amgen Inc. (AMGN)
Incyte Corporation (INCY)
Incyte Corporation (INCY)
Amgen Inc. (AMGN) Management Presents at The Bank of America Merrill Lynch Global Healthcare Conference (Transcript)
Sep. 18, 2019 9:01 AM ET | About: Amgen Inc. (AMGN)
Amgen Inc. (AMGN)
Incyte Corporation (INCY)
: Novartis AG (NVS)
Amgen (AMGN) Presents At ESMO Congress 2019 - Slideshow
Oct. 2, 2019 12:20 PM ET | About: Amgen Inc. (AMGN)
: Novartis AG (NVS)
Bristol-Myers Squibb Company (BMY)
: Novartis AG (NVS)
Novartis AG (NVS) Updates on Kisqali® MONALEESA-3 ESMO Data - Slideshow
Oct. 1, 2019 1:15 PM ET | About: Novartis AG (NVS)
Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (BMY)
.
Bristol-Myers Squibb (BMY) Presents At ESMO Congress 2019 - Slideshow
Sep. 30, 2019 3:34 PM ET | About: Bristol-Myers Squibb Company (BMY)
AstraZeneca PLC (AZN)
Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (BMY)
AstraZeneca Group (AZN) Presents At ESMO Congress 2019 - Slideshow
Oct. 2, 2019 12:06 PM ET | About: AstraZeneca PLC (AZN)
Wainwright 21st Annual Global Investment Conference
CytoDyn (CYDY)
GW Pharmaceuticals plc (GWPH)
Sesen Bio, Inc. (SESN)
CytoDyn (CYDY) Investor Presentation - Slideshow
Sep. 16, 2019 12:51 PM ET | About: CytoDyn Inc. (CYDY)
Sesen Bio, Inc. (SESN)
GW Pharmaceuticals plc (GWPH)
Sesen Bio, Inc. (SESN)
Sesen Bio (SESN) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow
Sep. 16, 2019 1:51 PM ET | About: Sesen Bio, Inc. (SESN)
GW Pharmaceuticals plc (GWPH)
GW Pharmaceuticals plc (GWPH)
ProBeam 360 Proton Therapy System
GW Pharmaceuticals (GWPH) Investor Presentation - Slideshow
Sep. 16, 2019 1:53 PM ET | About: GW Pharmaceuticals plc (GWPH)
ProBeam 360 Proton Therapy System
Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;
ProBeam 360 Proton Therapy System
Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;
Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;
Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;
BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia
Mon September 16, 2019 6:30 AM|GlobeNewswire|About: BCTXF, INCY, MRK
BERKELEY, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (BCTXF) ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF)
VCF Care Pathway
Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;
Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;
earnings Call Slides Q2./HY 2019
EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M
EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M
EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M
Novo Nordisk A/S 2019 Q2 - Results - Earnings Call Slides
Aug. 14, 2019 3:43 PM ET | About: Novo Nordisk A/S (NVO)
Insulet Corporation (PODD)
EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M
EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M
Insulet (PODD) Presents At Canaccord Genuity Growth Conference - Slideshow
Aug. 13, 2019 2:31 PM ET | About: Insulet Corporation (PODD)
China Biologic Products Holdings, Inc. (CBPO)
EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M
China Biologic Products Holdings, Inc. (CBPO)
China Biologic Products Holdings, Inc. 2019 Q2 - Results - Earnings Call Slides
Aug. 7, 2019 12:12 PM ET | About: China Biologic Products Holdings, Inc. (CBPO) .
CRISPR Therapeutics AG (CRSP)
EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M
China Biologic Products Holdings, Inc. (CBPO)
CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow
Aug. 13, 2019 2:26 PM ET|2 comments | About: CRISPR Therapeutics AG (CRSP)
EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M
EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M
EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M
Sangamo Therapeutics, Inc. 2019 Q2 - Results - Earnings Call Slides
Aug. 13, 2019 1:47 PM ET | About: Sangamo Therapeutics, Inc. (SGMO)
EPS of $-0.25 beats by $0.04 Revenue of $35.99M (-20.52% Y/Y) beats by $6.37M
EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M
EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M
Intrexon Corporation 2019 Q2 - Results - Earnings Call Slides
Aug. 9, 2019 6:29 PM ET | About: Intrexon Corporation (XON)
earnings Call Slides Q2./HY 2019
EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M
EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M
EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M
Celgene Corporation 2019 Q2 - Results - Earnings Call Slides
Jul. 31, 2019 1:34 PM ET | About: Celgene Corporation (CELG)
Amarin Corporation plc (AMRN)
EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M
EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M
Amarin Corporation plc 2019 Q2 - Results - Earnings Call Slides
Jul. 31, 2019 10:18 AM ET | About: Amarin Corporation plc (AMRN)
EPS of $-0.05 beats by $0.04 Revenue of $30.14M (32.46% Y/Y) beats by $1.3M
EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M
EPS of $-0.05 beats by $0.04 Revenue of $30.14M (32.46% Y/Y) beats by $1.3M
Veracyte, Inc. 2019 Q2 - Results - Earnings Call Slides
Jul. 31, 2019 3:06 PM ET | About: Veracyte, Inc. (VCYT)
Abiomed, Inc. (ABMD)
Vertex Pharmaceuticals Incorporated (VRTX)
EPS of $-0.05 beats by $0.04 Revenue of $30.14M (32.46% Y/Y) beats by $1.3M
Abiomed, Inc. 2020 Q1 - Results - Earnings Call Slides
Aug. 1, 2019 10:03 AM ET | About: Abiomed, Inc. (ABMD)
Becton, Dickinson and Company (BDX)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Becton, Dickinson and Company 2019 Q3 - Results - Earnings Call Slides
Aug. 6, 2019 10:16 AM ET | About: Becton, Dickinson and Company (BDX)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated 2019 Q2 - Results - Earnings Call Slides
Jul. 31, 2019 4:58 PM ET | About: Vertex Pharmaceuticals Incorporated (VRTX)
©2018 MarketsandMarkets Research Private Ltd.
Biomarker Technologies Market
Biomarker Technologies Market
Biomarker Technologies Market
Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022
Efficacy Testing Market
Biomarker Technologies Market
Biomarker Technologies Market
Efficacy Testing Market by Product and Service (Consumables, Services), Type (Antimicrobial Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products) - Global Forecast to 2022
Oncology Nutrition Market
Biomarker Technologies Market
Oncology Information System Market
Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
Oncology Information System Market
Non Invasive Prenatal Testing (NIPT) Market
Oncology Information System Market
Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital, Government Institution, & Research Center) - Global Forecasts to 2019
Non Invasive Prenatal Testing (NIPT) Market
Non Invasive Prenatal Testing (NIPT) Market
Non Invasive Prenatal Testing (NIPT) Market
Non Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021
Bioinformatics Market
Non Invasive Prenatal Testing (NIPT) Market
Non Invasive Prenatal Testing (NIPT) Market
Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023
©2018 BlackRock, Inc. All Rights Reserved.
Sep 25, 2018 By Bob Miller, Rick Rieder
An exceptionally strong labor market and reasonably firm inflation
have the Fed monitoring the heat in the U.S. economy.
September 2018 -
BlackRock Investment Institute
We see a growing disconnect between waning market attention to our top 10 geopolitical risks and the likelihood of some of them escalating. Our global BlackRock Geopolitical Risk Indicator (BGRI) has declined since our last update, suggesting the market’s attention to geopolitical risks overall has edged down. Yet the overall reading masks considerable dispersion, and we have raised the likelihood of three of our risks.Global trade tensions is our focus risk this month as U.S. trade disputes with major trading partners carry on.
Sep 19, 2018 - By Russ Koesterich
At $3.5 trillion per year, total healthcare spending (public and private) makes up roughly 20% of the U.S. economy. The nation’s 80 million baby boomers provide a stable source of ongoing revenue growth for healthcare companies throughout the value chain. Demographic tailwinds are widely expected to continue to propel this secular story in the United States.
Sep 14, 2018 By Michael Fredericks
In the United States, we continue to observe above-trend fundamental data, including strong corporate earnings, capital expenditures (business investment) and consumer sentiment. U.S. stocks notably outperformed international markets, with the S&P 500 Index rallying over 3% in August whereas European equities, for instance, were negative. We believe U.S. outperformance will likely persist in the near-term, underscoring our preference for more domestic-oriented assets.
Oct 1, 2018
By BlackRock Investment Institute
We see the steady global expansion rolling on, underpinned by above-trend U.S. growth. Yet the range of potential economic outcomes is widening. Gradual increases in U.S. rates are tightening financial conditions globally, and have contributed to bouts of volatility and sharply depreciating emerging market (EM) currencies. We also take a deep dive into the prospects for EMs after an unexpectedly drawn-out selloff.
Oct 8, 2018 By Richard Turnill
Global equities’ nearly decade-long bull run is stoking anxiety about its ability to power on. One concern: narrow breadth — a fragile state when a small group of stocks is contributing the lion’s share of market returns, buoying the broader index. We see today’s strong equity performance, especially in the U.S., as broad-based and driven by healthy fundamentals and solid earnings momentum.
© 2018 Grand View Research, Inc. All rights reserved.
Posted On Sep, 05, 2018
Cancer Biomarkers Market: Increasing demand for rapid and specific cancer diagnosis
Posted On Sep, 05, 2018
Regenerative Medicine: Presence of strong product pipeline coupled with emerging applications in gene therapy projected to drive market
Increasing number of surgical procedures is driving the surgical instruments market
Posted On Sep, 05, 2018
Biosimilars - A Pioneering Approach To Futuristic Treatments!
June 2018
The global genomics market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 9.7% during the forecast period.
Published Date: Sep, 2018
Metagenomics Market Size, Share & Trends Analysis Report By Product (Sequencing & Data Analytics), By Technology (Sequencing, Function), By Application (Environmental), And Segment Forecasts, 2018 - 2025
Some of the prominent players operating in this market are Illumina, Inc.; Promega Corporation; Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific, Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup.